MARCH9 Antikörper (C-Term)
Kurzübersicht für MARCH9 Antikörper (C-Term) (ABIN6743174)
Target
Alle MARCH9 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- C-Term
-
Spezifität
- Human MARCH9
-
Homologie
- Percent identity by BLAST analysis:
-
Aufreinigung
- Immunoaffinity purified
-
Immunogen
-
Synthetic peptide from C-Terminus of human MARCH9 (Q86YJ5, NP_612405). Percent identity by BLAST analysis: Human, Chimpanzee, Gorilla, Gibbon, Galago, Marmoset, Mouse, Rat, Elephant, Dog, Bovine, Bat, Rabbit, Horse, Pig, Guinea pig (100%), Monkey (92%).
Type of Immunogen: Synthetic peptide
-
-
anti-Membrane-Associated Ring Finger (C3HC4) 9 (MARCH9) (AA 240-345) antibody
MARCH9 Reaktivität: Human WB, ELISA, IF Wirt: Maus Monoclonal 2B5 unconjugated
anti-Membrane-Associated Ring Finger (C3HC4) 9 (MARCH9) (AA 304-330), (C-Term) antibodyMARCH9 Reaktivität: Human WB Wirt: Kaninchen Polyclonal RB37811 unconjugated
anti-Membrane-Associated Ring Finger (C3HC4) 9 (MARCH9) (AA 277-346) antibodyMARCH9 Reaktivität: Human WB, IF Wirt: Kaninchen Polyclonal unconjugated
anti-Membrane-Associated Ring Finger (C3HC4) 9 (MARCH9) (N-Term) antibodyMARCH9 Reaktivität: Human, Maus WB, ELISA Wirt: Kaninchen Polyclonal unconjugated
-
-
Applikationshinweise
-
Approved: WB (0.2 - 1 μg/mL)
Usage: Western Blot: Suggested dilution at 1 μg/mL in 5 % skim milk / PBS buffer, and HRP conjugated anti-Rabbit IgG should be diluted in 1: 50,000 - 100,000 as secondary antibody. -
Kommentare
-
Target Species of Antibody: Human
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Lyophilized
-
Rekonstitution
- Distilled water
-
Konzentration
- Lot specific
-
Buffer
- Lyophilized from PBS with 2 % sucrose
-
Handhabung
- Avoid repeat freeze-thaw cycles.
-
Lagerung
- 4 °C,-20 °C
-
Informationen zur Lagerung
-
Long term: -20°C, the use of 50% glycerol is recommended if storing aliquots in -20°C for long term use (up to 1 year)
Short term (less than 1 week): 4°C. Avoid freeze-thaw cycles.
-
-
-
